Recorded fact · drug.label_indication
drug.label_indication for dupilumab|atopic-dermatitis
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact c0e93e4f resolves to.
The record
| Fact id | c0e93e4fab38dc0b50692c52 |
|---|---|
| Entity | drug: dupilumab|atopic-dermatitis |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260422 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
Atopic Dermatitis for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe AD whose disease is not adequately controlled with topical prescription therapies or
Shown with dashes as hyphens. SHA-256 of the exact stored quote: a508a9ad6b53f31c48bde99046da54fd97845ff61e5a3be3892708685d5ec220.
The value
{
"ingredient": "Dupilumab",
"conditionId": "atopic-dermatitis",
"conditionName": "Atopic dermatitis",
"matchedAlias": "Atopic Dermatitis",
"context": "indication",
"brand": "Dupixent",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "595f437d-2729-40bb-9c62-c8ece1f82780",
"labelEffectiveTime": "20260422",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 92dbfeb361fbd75d1c9fd8f38dd128ed82f1dd617fbd30fd1200dc7349df8aef.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.